Acute Psychotic Symptoms Clinical Trial
— FAST-OOfficial title:
Quality Project to Evaluate and Validate the FAST-O Rating Scale (Fast ASessment in Acute Treatment of Psychosis-Observation)
| Verified date | October 2009 |
| Source | AstraZeneca |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Sweden: Regional Ethical Review Board |
| Study type | Observational |
The purpose of this project is to test the reliability of the FAST-O Rating Scale in patients at acute wards or psychiatric intensive care units.
| Status | Completed |
| Enrollment | 111 |
| Est. completion date | October 2009 |
| Est. primary completion date | |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - Patients with acute psychotic symptoms attending the acute ward or psychiatric intensive care unit Exclusion Criteria: |
Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| Sweden | Research Site | Helsingborg | |
| Sweden | Research Site | Kristianstad | |
| Sweden | Research Site | Lund | |
| Sweden | Research Site | Malmo | |
| Sweden | Research Site | Ystad |
| Lead Sponsor | Collaborator |
|---|---|
| AstraZeneca |
Sweden,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Reliability test of the FAST-O rating scale based on observational symptom ratings of patients with acute psychotic diseases | Each patients symtoms will be rated on 2 occasions, by 2-3 raters, each. First is made within 24 hrs of admission to acute psychiatric care, secondis made 14 +/- 2 days after admittance, or earlier if the patient is discharged. | No |